BioNTech SE BNTX
NASDAQ BNTX
$87.22 +0.01 (+0.01%)
As of: Nov 11, 2026 · 3:13 PM EST

BioNTech SE (BNTX) Return on Sales [ROS] (2018 - 2026)

Updated

BioNTech SE (BNTX) reported Return on Sales [ROS] of 9.70% for Q3 2026, up 12.78 percentage points from -3.09% a year earlier and up 907.52 percentage points from the prior quarter.

Analysis

BioNTech SE (BNTX) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, BioNTech SE's Return on Sales [ROS] came in at -75.96%, down 46.96 percentage points year-over-year; for FY2025, it was -48.95%, down 1.18 percentage points from FY2024.

  • Return on Sales [ROS] has declined for four consecutive years, with a five-year change of -31.87 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -47.77% in FY2024 (-65.85 pp), 18.08% in FY2023 (-54.96 pp), 73.03% in FY2022 (-7.51 pp) and 80.54% in FY2021 (+97.62 pp).
  • The Q3 2026 figure ranks as the highest quarterly Return on Sales [ROS] since Q4 2024.
  • Year over year, Return on Sales [ROS] gained in two of the last eight quarters, with an average year-over-year change of -64.09 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q2 2025 (a gain of 558.60 percentage points); the low point was Q2 2026 (a drop of 705.68 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -897.82% (Q2 2026), -573.67% (Q1 2026) and -35.57% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 BioNTech SE 22.05 Bn -37.46 Bn 1.36 Bn 9.70%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.70%
Jun 30, 2026 -897.82%
Mar 31, 2026 -573.67%
Dec 31, 2025 -35.57%
Sep 30, 2025 -3.09%
Jun 30, 2025 -192.14%
Mar 31, 2025 -292.18%
Dec 31, 2024 12.49%
Sep 30, 2024 0.84%
Jun 30, 2024 -750.74%
Mar 31, 2024 -270.36%
Dec 31, 2023 35.58%
Sep 30, 2023 8.16%
Jun 30, 2023 -335.90%
Mar 31, 2023 51.25%
Dec 31, 2022 76.97%
Sep 30, 2022 68.98%
Jun 30, 2022 69.13%
Mar 31, 2022 74.56%
Dec 31, 2021 84.95%
API Access

BioNTech SE Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BNTX&period=max&api_key=YOUR_API_KEY